Abstract |
Ulcerative Colitis (UC) is a chronic disease, in the progression of which an immune overreaction may play an important role. IL-22 is a member of the IL-10 superfamily of cytokines and is pleiotropic in immune regulation and inflammatory responses. IL-22 can produce protective effects, promote wound healing and tissue regeneration, while it can also induce inflammatory reactions when it is chronically overexpressed. Extensive literatures reported that IL-22 played an essential role in the pathogenic development of UC. IL-22 participates in the whole disease process of UC involving signaling pathways, gene expression regulation, and intestinal flora imbalance, making IL-22 a possible candidate for the treatment of UC. In this paper, the latest knowledge to further elucidate the role of IL-22 in UC was summarized and analyzed.
|
Authors | Nan Zhao, Chuanguo Liu, Ning Li, Shuang Zhou, Yuting Guo, Shihua Yang, Huimin Liu |
Journal | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
(Biomed Pharmacother)
Vol. 159
Pg. 114273
(Mar 2023)
ISSN: 1950-6007 [Electronic] France |
PMID | 36696801
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved. |
Chemical References |
- interleukin-22
- Interleukins
- Cytokines
|
Topics |
- Humans
- Colitis, Ulcerative
(pathology)
- Interleukins
(metabolism)
- Cytokines
(metabolism)
- Inflammation
|